Bavarian strikes a new deal with the US government
Bavarian Nordic has signed a contract with the US authorities, which could earn the company several million Danish kroner.
af LEONORA BECK
Bavarian Nordic has struck a new, five-year deal with the US government. The aim of the development contract is to examine if the Danish biotech company’s vaccine technology can be used within other disease areas.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
- Adgang til alle låste artikler
- Modtag vores daglige nyhedsbreve
- Fuld adgang til vores app
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler:
CEO: Greater chances of more vaccine orders from the US
For abonnenter
.jpg&w=384&q=75){kind=logo}
